Reference1210

Reference1210 is a small molecule drug studied primarily for metastatic breast cancer. It has been investigated in pharmacokinetic and bioequivalence studies, notably in comparison with SPARC1210, another investigational drug. The clinical trial involving Reference1210 was sponsored by Sun Pharma Advanced Research Company Limited and focused on patients with locally recurrent or metastatic breast cancer suitable for taxane-based therapy. The study aimed to evaluate bioavailability and pharmacokinetics but was terminated before completion. Specific mechanism of action details are not publicly available, but it is categorized as a small molecule drug developed for oncological indications.